Regeneron Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
REGN Nasdaq 2836 www.regeneron.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Regeneron Pharmaceuticals, Inc.

Vertex (VRTX) or Regeneron (REGN)? Two Biotech Moats, Two Very Different Bets - Oct 2nd, 2026 8:40 pm
Stocktwits Biotech Dealmaker — Novartis, Sanofi And Novo Sign Week’s Biggest Deals - Oct 2nd, 2026 6:13 pm
An $8 Billion Reason Why Regeneron Stock Is in Focus - Oct 2nd, 2026 12:21 pm
This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking - Oct 2nd, 2026 9:00 am
Sanofi, Regeneron Expand Immunology Alliance With New Antibodies - Oct 2nd, 2026 6:45 am
Sanofi pays Regeneron up to $8B to expand immunology alliance - Oct 2nd, 2026 6:26 am
Vertex Pharmaceuticals And 2 Other Top Gene Therapy Stocks - Oct 1st, 2026 4:07 pm
Why Regeneron (REGN) Stock Is Trading Lower Today - Oct 1st, 2026 4:05 pm
OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD - Oct 1st, 2026 3:35 pm
Sanofi, Regeneron broaden alliance to find their next Dupixent - Oct 1st, 2026 9:38 am
Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC) - Oct 1st, 2026 9:35 am
Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss - Oct 1st, 2026 9:30 am
Pfizer’s eczema drug clears skin in mid-stage trial - Oct 1st, 2026 9:03 am
Regeneron, Sanofi Expand Alliance in Deal Worth Up to $8 Billion - Oct 1st, 2026 9:02 am
Kodiak Sciences More Than Doubles on Eye Disease Trial Results - Oct 1st, 2026 8:57 am
Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal - Oct 1st, 2026 8:48 am
Sanofi, Regeneron Expand DUPIXENT Alliance in Deal Worth Up to €8 Billion - Oct 1st, 2026 8:03 am